Skip to main content
OpenTrials

Clinical trial condition

Spondylarthropathies

Explore clinical trials studying Spondylarthropathies. Study availability and eligibility vary by location and protocol.

825 public trials 129 recruiting studies
Refine in advanced search Browse all conditions

Spondylarthropathies trial results

Completed

Study to Examine the Clinical Efficacy and the Nonsteroidal Anti-inflammatory Drug (NSAID)-Sparing Effect of Secukinumab Over 16 Weeks in Patients With Ankylosing Spondylitis

NCT02763046

Conditions
Ankylosing Spondylitis, Ankylosis, Arthritis, +9 more
Locations
  • Novartis Investigative Site Bad Doberan, Germany
  • Novartis Investigative Site Bayreuth, Germany
  • Novartis Investigative Site Berlin, Germany
  • Novartis Investigative Site Berlin, Germany
View all 39 locations
View Trial Details
Completed

Study to Evaluate the Safety and Efficacy of Secukinumab 300 mg and 150 mg in Adult Patients With Active Psoriatic Arthritis (PsA) After 16 Weeks of Treatment Compared to Placebo

NCT02798211

Conditions
Arthritis, Arthritis, Psoriatic, Bone Diseases, +13 more
Locations
  • Novartis Investigative Site Birmingham, Alabama, United States
  • Novartis Investigative Site Little Rock, Arkansas, United States
  • Novartis Investigative Site El Cajon, California, United States
  • Novartis Investigative Site Fountain Valley, California, United States
View all 58 locations
View Trial Details
Completed

Efficacy and Safety of Tofacitinib in Subjects With Active Ankylosing Spondylitis (AS)

NCT03502616

Conditions
Ankylosing Spondylitis, Ankylosis, Arthritis, +9 more
Locations
  • Rheumatology Associates of North Alabama, PC Huntsville, Alabama, United States
  • Arizona Arthritis & Rheumatology Associates, P.C. Gilbert, Arizona, United States
  • Medvin Clinical Research Covina, California, United States
  • Rheumatology Center of San Diego PC San Diego, California, United States
View all 99 locations
View Trial Details
Completed

SKIPPAIN - Speed of Onset of SecuKinumab-Induced Relief From Pain in Patients With AxIal SpoNdyloarthritis

NCT03136861

Conditions
Ankylosis, Arthritis, Axial Spondyloarthritis, +10 more
Locations
  • Novartis Investigative Site Brussels, Belgium
  • Novartis Investigative Site Liège, Belgium
  • Novartis Investigative Site Burgas, Bulgaria
  • Novartis Investigative Site Plovdiv, Bulgaria
View all 66 locations
View Trial Details

Related conditions